Literature DB >> 8373003

IgE and non-IgE mechanisms in ocular allergy.

S Bonini1, S Bonini1.   

Abstract

Various forms of conjunctival disease have traditionally been referred to by the umbrella term "allergic conjunctivitis," on the assumption that they are all caused by a Gell and Coombs type I hypersensitivity reaction. Recent evidence disputes this classification, however, and suggests that other mechanisms may also be responsible for the complex clinical features of conjunctival disease. Among these are non-IgE-mediated activation of mast cells, late-phase reactions, and nonspecific conjunctival hyperreactivity. The authors suggest that the pathophysiology of allergic eye disease is multifactorial, which explains the different clinical pictures seen in different patients. Both IgE-mediated and non-IgE-mediated mechanisms may cause an immediate reaction as well as allergic inflammation, and nonspecific hyperreactivity may occur both as a result of allergic inflammation and as an independent mechanism in nonallergic conjunctival disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8373003

Source DB:  PubMed          Journal:  Ann Allergy        ISSN: 0003-4738


  3 in total

1.  Efficacy of topical cyclosporin A 0.05% in conjunctival impression cytology specimens and clinical findings of severe vernal keratoconjunctivitis in children.

Authors:  Ugur Keklikci; Sevda I Soker; Yildirim B Sakalar; Kaan Unlu; Selver Ozekinci; Selcuk Tunik
Journal:  Jpn J Ophthalmol       Date:  2008-11-11       Impact factor: 2.447

2.  Childhood chronic anterior uveitis associated with vernal keratoconjunctivitis (VKC): successful treatment with topical tacrolimus. Case series.

Authors:  Andrea Taddio; Rolando Cimaz; Roberto Caputo; Cinzia de Libero; Laura Di Grande; Gabriele Simonini; Francesca Mori; Elio Novembre; Neri Pucci
Journal:  Pediatr Rheumatol Online J       Date:  2011-11-02       Impact factor: 3.054

3.  Exacerbation of signs and symptoms of allergic conjunctivitis by a controlled adverse environment challenge in subjects with a history of dry eye and ocular allergy.

Authors:  Paulo J Gomes; George W Ousler; Donna L Welch; Lisa M Smith; Jeffrey Coderre; Mark B Abelson
Journal:  Clin Ophthalmol       Date:  2013-01-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.